High pretreatment disease burden as a risk factor for infectious complications following CD19 chimeric antigen receptor T‐cell therapy for large B‐cell lymphoma

Abstract Infection has emerged as the chief cause of non‐relapse mortality (NRM) post CD19‐targeting chimeric antigen receptor T‐cell therapy (CAR‐T) therapy. Even though up to 50% of patients may remain infection‐free, many suffer multiple severe, life‐threatening, or fatal infectious events. The p...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Maeve A. O'Reilly, Lorna Neill, Simon M. Collin, Neil Stone, Deborah Springell, Jeremy Mensah, Kathleen P. L. Cheok, Katarzyna Jalowiec, Reuben Benjamin, Andrea Kuhnl, Claire Roddie, Robin Sanderson
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2024-01-01
coleção:	HemaSphere
Acesso em linha:	https://doi.org/10.1002/hem3.29
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!